ENTRY       D10572            Mixture   Drug
NAME        Fosnetupitant and palonosetron hydrochloride;
            Netupitant and palonosetron hydrochloride;
            Akynzeo (TN)
PRODUCT     AKYNZEO (Helsinn Therapeutics (U.S.))
COMPONENT   (Netupitant [DR:D05152] | Fosnetupitant [DR:D11065]), (Palonocetron hydrochloride [DR:D05343] | Palonosetron [DR:D07175])
CLASS       Metabolizing enzyme substrate
             DG01642  CYP2C9 substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      ATC code: A04AA55
            Product: D10572<US>
EFFICACY    Anti-emetic
COMMENT     Netupitant is metabolized by CYP3A4 with some contribution from CYP2C9 and CYP2D6.
METABOLISM  Enzyme: CYP3A4 [HSA:1576]; CYP2C9 [HSA:1559], CYP2D6 [HSA:1565]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A04 ANTIEMETICS AND ANTINAUSEANTS
               A04A ANTIEMETICS AND ANTINAUSEANTS
                A04AA Serotonin (5HT3) antagonists
                 A04AA55 Palonosetron, combinations
                  D10572  Fosnetupitant and palonosetron hydrochloride &lt;US&gt;
            USP drug classification [BR:br08302]
             Antiemetics
              Emetogenic Therapy Adjuncts
               Fosnetupitant/ Palonosetron
                D10572  Fosnetupitant and palonosetron hydrochloride
               Netupitant/ Palonosetron
                D10572  Fosnetupitant and palonosetron hydrochloride
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01642  CYP2C9 substrate
               D10572  Fosnetupitant and palonosetron hydrochloride
              DG01644  CYP2D6 substrate
               D10572  Fosnetupitant and palonosetron hydrochloride
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D10572  Fosnetupitant and palonosetron hydrochloride
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10572
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10572
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10572
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10572
DBLINKS     PubChem: 254741534
            ChEBI: 85154
///
